ノースカロライナにおける冠動脈疾患の臨床試験
ノースカロライナ内の拠点で、冠動脈疾患に関する19件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
- Sanger Heart & Vascular Institute, Charlotte
- Duke University Hospital, Durham
被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/05更新 · NCT07559903Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Asheville Cardiology Associates Research Department, Asheville
- Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
- Mecklenburg Heart Specialists, Charlotte
- 他6件
被験者募集中第4相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06909565Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Mission Health, Asheville
被験者募集中
18歳〜90歳 · 全性別 · 2026/09/30更新 · NCT07296744A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- NC Heart and Vascular Research, LLC, Raleigh
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- 他3件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05485961Product Surveillance Registry
- Chapel Hill
- Charleston
- Durham
- 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/18更新 · NCT01524276Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
- Duke University, Durham
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/11更新 · NCT07048808REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
- Duke University, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Duke University, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06399692A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Clinical Study Center, High Point
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/09/02更新 · NCT06164730Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Carolina East Medical Center, New Bern
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/19更新 · NCT02061436Virtue® SAB in the Treatment of Coronary ISR Trial
- Mission Hospital, Asheville
被験者募集中
18歳以上 · 全性別 · 2026/07/23更新 · NCT07045194Prevail Global Study
- The Moses H Cone Memorial Hospital, Greensboro
- Novant Health New Hanover Regional Medical Center, Wilmington
被験者募集中
18歳以上 · 全性別 · 2026/04/24更新 · NCT06535854The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
- Durham VA Medical Center, Durham, NC, Durham
被験者募集中第4相
18歳以上 · 全性別 · 2026/04/22更新 · NCT05618353Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Duke University, Durham
- East Carolina University, Greenville
- Wake Forest University, Winston-Salem
被験者募集中
18歳以上 · 女性 · 2026/04/01更新 · NCT04124120Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Durham VA Medical Center, Durham, NC, Durham
被験者募集中第4相
18歳以上 · 全性別 · 2025/12/17更新 · NCT02915198MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NC Heart and Vascular Research, LLC, Raleigh
被験者募集中
18歳〜80歳 · 全性別 · 2025/09/11更新 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Novant Health Heart and Vascular Institute, Charlotte
被験者募集中
全年齢 · 全性別 · 2025/07/24更新 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NC Heart and Vascular Research, LLC, Raleigh
被験者募集中
18歳〜110歳 · 全性別 · 2025/02/25更新 · NCT05908331ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。